Significant factors in red cell mass changes after fractionated local radiotherapy.
D000328:Adult; D000368:Aged; D001810:Blood Volume / Q000528:radiation effects; D001932:Brain Neoplasms / Q000532:radiotherapy; D001943:Breast Neoplasms / Q000532:radiotherapy; D002859:Chromium Isotopes; D003036:Cobalt Isotopes; D004912:Erythrocytes / Q000528:radiation effects*; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000532:radiotherapy; D006400:Hematocrit; D006801:Humans; D007456:Iodine Isotopes; D008175:Lung Neoplasms / Q000532:radiotherapy; D008297:Male; D008875:Middle Aged; D009062:Mouth Neoplasms / Q000532:radiotherapy; D010051:Ovarian Neoplasms / Q000532:radiotherapy; D010953:Plasma Volume / Q000528:radiation effects; D011867:Radioisotope Teletherapy / Q000009:adverse effects; D011878:Radiotherapy / Q000009:adverse effects*; D011879:Radiotherapy Dosage; D011882:Radiotherapy, High-Energy / Q000009:adverse effects; D001749:Urinary Bladder Neoplasms / Q000532:radiotherapy; D002583:Uterine Cervical Neoplasms / Q000532:radiotherapy
D002859:Chromium Isotopes; D003036:Cobalt Isotopes; D007456:Iodine Isotopes